Methods of treating diseases characterized by hyperexcitability

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544407, A61K 31495, C07D24120

Patent

active

048943762

ABSTRACT:
The invention provides methods of treating diseases characterized by hyperexcitability of neurons. An amount of a substituted pyrazinoylguanidine compound effective to regulate excitability of the neurons is administered. Substituted pyrazinoylguanidines having the formula ##STR1## wherein R is halogen and R.sup.1 is a member of the group consisting of hydrogen, benzyl and optionally substituted benzyl are useful in the invention. The invention also discloses a method of treating neurons having hyperexcitable cell membranes.

REFERENCES:
patent: 3240780 (1956-03-01), Cragoe et al.
patent: 3527758 (1970-09-01), Cragoe et al.
D. R. Bielefeld, et al., "3',4'-Dichlorobenzamil Inhibits Ca ad K Currents in Single Frog Atrial Cells", Circulation vol. 74, Abstract No. 686, 1986.
M. L. Garcia, et al.,. "Interaction of Amiloride Derivatives with the Cardiac Ca.sup.2 + Entry Blocker Receptor Complex", Biophysical Journal 51: 428a (1987).
Takehiko Amano, et al., "Neurotransmitter Synthesis by Neuroblastoma Clones", Proc. Nat. Acad. Sci USA 69: No. 1 258-263 (1972).
A. Pousti, et al.,. "Effect of Amiloride on Isolated Guinea-Pig Atrium", Arch. Int. Pharmacodyn. 242: 222-229 (1979).
Shuji Yamashita, et al.,. "Cardiac Effects of Amiloride in the Dog", Journal of Cardiovascular Pharmacology 3: 704-715 (1981).
Hamill, et al., "Improved Patch-Clamp Techniques for High-Resolution Current Recording from Cells and Cell-Free Membrane Patches", Pflugers Arch 391: 85-100 (1981).
Barde et al., "Sensory Neurons in Culture: Changing Requirements for Survival Factors During Embryonic Development", Proc. Natl. Acad. Sci USA, vol. 77: 1199-1203.
Tang, et al., "Amiloride Selectively Blocks the Low Threshold (T) Calcium Channel", Biophysical Journal, vol. 53 (1988).
Richard T. Johnson, Excerpt from Current Therapy in Neurologic Disease-2, (1987), pp. 45-47.
Miller et al., "Are Dihydropyridine Binding Sites Voltage Sensitive Calcium Channels?", Minireview, Life Sciences, vol. 34:1205-1221 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating diseases characterized by hyperexcitability does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating diseases characterized by hyperexcitability , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating diseases characterized by hyperexcitability will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1335005

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.